Language

News topic

Active ingredient Alizapride

Current shortage notices for the active ingredient Alizapride, structured by product, country and reporting period.

6 notices

← All shortages

What the Alizapride notices indicate for the supply chain

The 6 consolidated notices from Belgium are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Litican 50 mg/2 ml inj. sol. i.m./i.v. amp. 6 x 2 ml

Active ingredient: Alizapride

View notice details →
Belgium

Litican 50 mg/2 ml inj. sol. i.m./i.v. amp. 6 x 2 ml

Active ingredient: Alizapride

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.